|
SLC2A13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.633280E-04 |
| Normal-vs-Stage3 |
1.62458935193399E-12 |
| Normal-vs-Stage4 |
1.05170316899716E-11 |
| Stage1-vs-Stage2 |
4.553800E-01 |
| Stage1-vs-Stage3 |
5.869600E-01 |
| Stage1-vs-Stage4 |
3.130400E-01 |
| Stage2-vs-Stage3 |
6.666000E-01 |
| Stage2-vs-Stage4 |
1.910840E-01 |
| Stage3-vs-Stage4 |
1.561840E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
5.04309999982411E-07 |
| Normal-vs-Asian |
3.31439997669492E-09 |
| Caucasian-vs-AfricanAmerican |
8.722000E-01 |
| Caucasian-vs-Asian |
6.751000E-01 |
| AfricanAmerican-vs-Asian |
8.872600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
1.177990E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
2.63000732303453E-12 |
| Normal-vs-Age(81-100Yrs) |
1.694260E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.310400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.689000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.596000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.242400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.052400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.375000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.258600E-01 |
| Classical-VS-Follicular |
8.14150002970138E-09 |
| Classical-VS-Other |
4.882000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
4.435800E-04 |
| Tall-VS-Other |
5.908600E-01 |
| Tall-VS-Normal |
1.82810433457803E-11 |
| Follicular-VS-Other |
2.435800E-01 |
| Follicular-VS-Normal |
8.1133999996208E-07 |
| Other-VS-Normal |
2.505600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
2.44027020812609E-13 |
| N0-vs-N1 |
2.031400E-01 |
|
|
